Literature DB >> 22742546

Nonneoplastic lesions of the prostate and bladder.

Lara Rabih Harik1, Kathleen Mary O'Toole.   

Abstract

CONTEXT: Specimens from the prostate and bladder are commonly encountered by the general surgical pathologist. Emphasis is usually placed on neoplasms of the bladder and prostate, particularly if malignant, owing to their therapeutic consequences. A good command of benign lesions occurring in the bladder and prostate, and knowledge of their preneoplastic potential will help pathologists confidently diagnose malignancy versus its benign mimickers and guide the urologists in choosing the appropriate therapy and follow-up for the patient.
OBJECTIVE: To present a mixture of benign entities, and discuss their histologic and clinical characteristics, hoping to provide a practical review for the general surgical pathologist. DATA SOURCES: An extensive review of the literature on the entities discussed was performed.
CONCLUSIONS: A wide variety of benign entities are present in the prostate and bladder. Benign lesions in the prostate can be age related, such as prostatic atrophy and benign prostatic hyperplasia; transition zone associated, such as basal cell hyperplasia, adenosis, and sclerosing adenosis; or prostatic urethra associated. Benign lesions of the bladder encompass a wide variety of reactive changes that can occur in the urothelium, as well as hyperplastic lesions or reactive proliferations that could be misdiagnosed as malignant. The bladder responds to chronic irritation through several reactive/metaplastic lesions such as cystitis cystica/glandularis, keratinizing squamous metaplasia, or nephrogenic metaplasia. The urothelium can also give rise to hyperplastic/proliferative lesions, in particular von Brunn nest hyperplasia, papillary polypoid cystitis, and pseudocarcinomatous proliferation, which should be distinguished from malignant processes. Ectopic tissue, such as prostatic or mullerian, can also be seen.

Entities:  

Mesh:

Year:  2012        PMID: 22742546     DOI: 10.5858/arpa.2011-0584-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

1.  Gene Expression-Based Functional Differences between the Bladder Body and Trigonal Urothelium in Adolescent Female Patients with Micturition Dysfunction.

Authors:  Natalia Zeber-Lubecka; Maria Kulecka; Katarzyna Załęska-Oracka; Michalina Dąbrowska; Aneta Bałabas; Ewa E Hennig; Magdalena Szymanek-Szwed; Michał Mikula; Beata Jurkiewicz; Jerzy Ostrowski
Journal:  Biomedicines       Date:  2022-06-17

Review 2.  The pathology of urinary bladder lesions with an inverted growth pattern.

Authors:  Aitao Guo; Aijun Liu; Xiaodong Teng
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

3.  Cystitis Cystica as a Large Solitary Bladder Cyst.

Authors:  Stephanie Potts; John Calleary
Journal:  J Endourol Case Rep       Date:  2017-03-01

4.  Inflammation and Tissue Remodeling in the Bladder and Urethra in Feline Interstitial Cystitis.

Authors:  F Aura Kullmann; Bronagh M McDonnell; Amanda S Wolf-Johnston; Andrew M Lynn; Daniel Giglio; Samuel E Getchell; Wily G Ruiz; Irina V Zabbarova; Youko Ikeda; Anthony J Kanai; James R Roppolo; Sheldon I Bastacky; Gerard Apodaca; C A Tony Buffington; Lori A Birder
Journal:  Front Syst Neurosci       Date:  2018-04-13

5.  Incidence of adenocarcinoma bladder in patients with cystitis cystica et glandularis: A retrospective study.

Authors:  Amit Agrawal; Deepak Kumar; Aditya A Jha; Puneet Aggarwal
Journal:  Indian J Urol       Date:  2020-10-01

6.  Primary signet-ring cell carcinoma of the urinary bladder.

Authors:  Nirmalya Benerjee; Kalpesh Parmar; Kim Vaiphei
Journal:  Autops Case Rep       Date:  2021-04-22

7.  Urine cytology: Pitfall due to a "remnant" lesion.

Authors:  Michael Chaump; Tamar Giorgadze; Andrew M Schreiner
Journal:  Cytojournal       Date:  2015-07-28       Impact factor: 2.091

8.  Intestinal metaplasia of the bladder in 89 patients: a study with emphasis on long-term outcome.

Authors:  Zhixiang Xin; Chenhui Zhao; Tao Huang; Zhaohui Zhang; Chenlong Chu; Caifeng Lu; Min Wu; Wenlong Zhou
Journal:  BMC Urol       Date:  2016-06-07       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.